NCT04005638 Biological Bank for the Patients Followed in a Constitutive Reference Center for Autoimmune Cytopenia Status RECRUITING Phase N/A
NCT03998982 Glycyrrhetinic Acid Combined With Dexamethasone in Management of Newly Diagnosed ITP Status UNKNOWN Phase PHASE4
NCT03965624 Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia Status WITHDRAWN Phase PHASE2
NCT03939637 Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children Status COMPLETED Phase PHASE3
NCT03830749 Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura Status COMPLETED Phase PHASE2
NCT03810352 Association of Platelet Parameters With Bleeding Severity in Children With ITP Status COMPLETED Phase N/A
NCT03603132 A Study to Evaluate Different Intervals Between Dosing and Feeding on the Pharmacokinetics Status COMPLETED Phase PHASE1
NCT03520049 Proof-of-Concept: A Pilot, Randomized, Double-Blind Study of Oseltamivir Versus Placebo for Immune Thrombocytopenia Status UNKNOWN Phase PHASE3
NCT03492515 Recombinant Human Thrombopoietin(rhTPO) in Pregnancy With Immune Thrombocytopenia Status UNKNOWN Phase PHASE3
NCT03469661 Differential Diagnostic of Immune ThrombocytoPenia (ITP) and Myelodysplastic Syndrome (MDS) Status COMPLETED Phase N/A
NCT03460808 The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE1/PHASE2
NCT03443570 Rituximab Combining Bortezomib Versus Rituximab in Management of ITP Status UNKNOWN Phase PHASE3
NCT03395210 A Study of Rilzabrutinib in Adult Patients With Immune Thrombocytopenia (ITP) Status COMPLETED Phase PHASE2
NCT03377439 The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP Status UNKNOWN Phase N/A
NCT03324087 Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China Status UNKNOWN Phase N/A
NCT03304288 The Combination of Low-dose Rituximab and ATRA as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia Status UNKNOWN Phase PHASE2
NCT03258866 The Study of Different Dose Rituximab in the Treatment of ITP Status COMPLETED Phase PHASE4